Pill with imprint VYN 61 is Brown, Capsule/Oblong and has been identified as Vyndamax tafamidis 61 mg. It is supplied by Pfizer Inc.

VYNDAMAX 61-mg (tafamidis) soft gelatin capsules are reddish brown, opaque, oblong, and printed with “VYN 61” in white and supplied in the following package configurations:

2024年12月11日 · Vyndamax is taken as 1 capsule, 1 time per day. You cannot substitute Vyndamax for Vyndaqel on a mg-to-mg basis. But your healthcare provider can switch you …

In vitro tafamidis inhibits the efflux transporter BCRP (breast cancer resistant protein) at the 61 mg/day tafamidis dose with IC50=1.16 μM and may cause drug-drug interactions at clinically …

VYNDAMAX 61-mg (tafamidis) soft gelatin capsules are reddish brown, opaque, oblong, and printed with "VYN 61" in white and supplied in the following package configurations:

大鼠围产期发育的NOAEL为5 mg/kg/天（以体表面积计，约相当于人推荐剂量61 mg/天的0.8倍）。 转基因Tg.rasH2小鼠连续26周经口给予氯苯唑酸葡胺剂量达90 mg/kg/天（剂量以氯苯唑 …

2023年3月15日 · 【适应症】本品适 用于治疗成人野生型或遗传型转甲状腺素蛋白淀粉样变性心肌病（ATTR-CM），以减少心血管死亡及心血管相关住院。 【规格】61 mg 【用法用量】推荐 …

2022年4月27日 · 【性状】 本品为红棕色不透明的椭圆形软胶囊，印有白色“VYN 61”字样，内容物为白色至粉红色混悬液。 【适应症】 本品适用于治疗成人野生型或遗传型转甲状腺素蛋白淀 …

妊娠大鼠于器官形成期经口给予氯苯唑酸葡胺15、30、45 mg/kg/ 天(以氯苯唑酸计),≥30 mg/kg/ 天(以AUC 计,暴露量约相当于人推荐剂量61 mg/ 天时暴露量的9.5倍)时可致胎仔体重降低,大鼠 …

Includes images and details for pill imprint VYN 61 including shape, color, size, NDC codes and manufacturers.